Archives

14 Nov

BUILDING A LOW-CARBON, CLIMATE RESILIENT FUTURE: SECURE, CLEAN AND EFFICIENT ENERGY

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-LC-SC3-2018-2019-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Tue, 3 Sep 2019 17:00:00 (Brussels local time)Modification Date: Wed, 14

13 Nov

Expansion Therapeutics Hires Elliot Enrich as CMO

Expansion Therapeutics has hired Elliot Ehrich as its chief medical officer. Ehrich was most recently CMO and executive vice president

13 Nov

Energy Transition – the Pathway Towards a Low–Carbon Europe – 27 November 2018, Brussels, Belgium

[Source: Research & Innovation] We know that the world needs a climate friendly energy system that can provide power for

12 Nov

Veritas, Elliott Strike $5.7B Deal for Athenahealth

[Updated 11/12/18, 10:31 am, with deal terms.] Athenahealth has reached an agreement to be bought for approximately $5.7 billion in

12 Nov

This British Celebrity Spoke Powerfully About What He Has Learned Since His Son Came Out

“Just love them for who they are and allow them to feel safe. And those little digs and the little

10 Nov

Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder

Two months ago, the medical community was all abuzz over a big clinical study that showed a prescription fish-oil supplement

10 Nov

Salk Team Awarded 8-Year, $19.2M Grant for Alzheimer’s Research

A 10-person team of researchers at the Salk Institute for Biological Studies has been awarded an eight-year, $19.2 million grant

09 Nov

Eyeing $500M, Moderna Outlines Plans for Biotech’s Biggest IPO Ever

One of the biggest gambles in biotech history is about to be tested on Wall Street. Moderna, the high-flying yet

09 Nov

Call for proposals for ERC Synergy Grant

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: ERC-2019-SyGPillar: Excellent ScienceOpening Date: Deadline: Thu, 8 Nov 2018 17:00:00 (Brussels local time)Modification Date: Fri, 9 Nov

09 Nov

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

The biotech industry recently realized its 300th IPO since the Jumpstart Our Business Startups (JOBS) Act was enacted in 2012.